Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.4.2 has been added and the government funding status notice, along with the Revision: v3.4.1 label, was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoChange DetectedA government funding/status notice was added and the page template updated to Revision: v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check17 days agoChange DetectedFooter and help-section updates were made, including glossary display and IPD-related links. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference55%

- Check53 days agoChange DetectedA new Locations section is added, listing Osaka and additional prefectures (Aichi-ken, Hokkaido, Kumamoto, Shizuoka, Tokyo) and the page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and prior location entries (Aichi-ken Locations, Hokkaido Locations, Kumamoto Locations, Shizuoka Locations, Tokyo Locations) were removed.SummaryDifference0.6%

- Check74 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the Study Details page. No study data, eligibility criteria, outcomes, or locations appear to be affected.SummaryDifference0.1%

- Check81 days agoChange DetectedMinor site revision update from v3.2.0 to v3.3.1; no changes to study content or essential page details were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.